Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

32.22
Delayed Data
As of Jan 20
 -0.62 / -1.89%
Today’s Change
20.39
Today|||52-Week Range
37.32
-3.82%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Or Yat Sun
Chief Scientific Officer
Sale1/04/201713,921$35.09$488.5K-10.23%
Or Yat Sun
Chief Scientific Officer
Sale11/29/201613,921$31.44$437.7K+2.97%
Luly Jay R
President & Chief Executive Officer
Buy6/10/201641,645$2.97$123.7K+38.11%
Luly Jay R
President & Chief Executive Officer
Buy5/10/201625,000$2.97$74.3K+31.40%
Vance Terry
Director
Buy2/12/20162,000$27.04$54.1K+20.67%
Luly Jay R
President & Chief Executive Officer
Buy3/09/201618,561$2.54$47.1K+12.82%
Gardiner Nathaniel S
General Counsel & Senior Vice President
Buy5/11/2016500$24.44$12.2K+33.80%
Mellett Paul J
Chief Financial Officer & Treasurer
Buy2/26/20166,689$1.29$8.6K+13.45%